{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:52:20Z","timestamp":1794009140958,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010454","name":"Bracco Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010454","name":"Bracco Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010454","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.xkme.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T08:17:49Z","timestamp":1579681069000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Matthew S.","family":"Davenport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Dillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Rodby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xkme.2020.01.001_bib1","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2214\/AJR.14.14259","article-title":"Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction","volume":"204","author":"Davenport","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.001_bib2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2214\/AJR.13.11369","article-title":"The challenges in assessing contrast-induced nephropathy: where are\u00a0we now?","volume":"202","author":"Davenport","year":"2014","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1148\/radiol.10092000","article-title":"Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?","volume":"256","author":"Katzberg","year":"2010","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00134-017-4950-6","article-title":"Contrast-associated acute kidney injury is a myth: Yes","volume":"44","author":"Ehrmann","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00134-017-5015-6","article-title":"Contrast-associated acute kidney\u00a0injury is a myth: No","volume":"44","author":"Weisbord","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00134-017-4970-2","article-title":"Contrast-associated acute kidney\u00a0injury is a myth: We are not sure","volume":"44","author":"Kashani","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1148\/radiol.12121394","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material","volume":"267","author":"Davenport","year":"2013","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.001_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/radiol.13122276","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate","volume":"268","author":"Davenport","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.12121460","article-title":"Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis","volume":"267","author":"McDonald","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.12121823","article-title":"Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?","volume":"267","author":"McDonald","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"McDonald","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1148\/radiol.13122876","article-title":"Quantitating contrast medium-induced nephropathy: controlling the controls","volume":"267","author":"Newhouse","year":"2013","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.001_bib13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2214\/AJR.17.19499","article-title":"Propensity score matching as a substitute for randomized controlled trials on acute kidney injury after contrast media administration: a systematic review","volume":"211","author":"Dekkers","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.xkme.2020.01.001_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris","year":"2011","journal-title":"J\u00a0R Soc Med"},{"issue":"12","key":"10.1016\/j.xkme.2020.01.001_bib16","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1007\/s00330-018-5678-6","article-title":"Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines","volume":"28","author":"Nyman","year":"2018","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.001_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury","volume":"61","author":"Palevsky","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2020.01.001_bib18","series-title":"Standards for intravascular contrast administration to adult patients","year":"2015"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.001_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1148\/radiol.2019182220","article-title":"Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial","volume":"292","author":"Sch\u00f6nenberger","year":"2019","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.001_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1148\/radiol.2392050413","article-title":"Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis","volume":"239","author":"Rao","year":"2006","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2011.32","article-title":"Section 2: AKI definition","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.001_bib22","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.001_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.1990.182","article-title":"Measurement of renal function in chronic renal disease","volume":"38","author":"Levey","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2020.01.001_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejrad.2019.03.008","article-title":"Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies","volume":"116","author":"Faucon","year":"2019","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.001_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11255-010-9798-4","article-title":"Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease","volume":"42","author":"Rosenstock","year":"2010","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.001_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00330-017-5023-5","article-title":"Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines","volume":"28","author":"Stacul","year":"2018","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.001_bib29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2214\/AJR.10.5152","article-title":"Incidence of\u00a0contrast-induced nephropathy in patients with multiple myeloma\u00a0undergoing contrast-enhanced CT","volume":"196","author":"Pahade","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.001_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12253-017-0300-9","article-title":"Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced procedures","volume":"24","author":"Crowley","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.xkme.2020.01.001_bib31","series-title":"Contrast-induced nephropathy: comparative effects of different contrast media","author":"Eng","year":"2015"},{"key":"10.1016\/j.xkme.2020.01.001_bib32","series-title":"Contrast-induced nephropathy: comparative effectiveness of preventive measures","author":"Subramaniam","year":"2016"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2215\/CJN.02580607","article-title":"Prevention of contrast-induced nephropathy with volume expansion","volume":"3","author":"Weisbord","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2020.01.001_bib34","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/RLI.0000000000000570","article-title":"Prophylaxis in High-Risk Patients With eGFR\u00a0< 30 mL\/min\/1.73 m2: Get the Balance Right","volume":"54","author":"Nijssen","year":"2019","journal-title":"Invest Radiol"},{"issue":"10076","key":"10.1016\/j.xkme.2020.01.001_bib35","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","article-title":"Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy\u00a0(AMACING): a prospective, randomised, phase 3,\u00a0controlled, open-label, non-inferiority trial","volume":"389","author":"Nijssen","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.001_bib36","doi-asserted-by":"crossref","first-page":"W188","DOI":"10.2214\/AJR.19.21424","article-title":"Influence of clinical factors on risk of contrast-induced nephrotoxicity from IV iodinated low-osmolality contrast material in patients with a low estimated glomerular filtration rate","volume":"213","author":"Ellis","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.xkme.2020.01.001_bib37","first-page":"2856","article-title":"Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur\u00a0Radiol"},{"issue":"12","key":"10.1016\/j.xkme.2020.01.001_bib38","first-page":"618","article-title":"Oral hydration for prevention of contrast-induced acute kidney injury in elective radiological procedures: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Cheungpasitporn","year":"2014","journal-title":"N\u00a0Am J Med Sci"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib39","doi-asserted-by":"crossref","first-page":"e000317","DOI":"10.1136\/openhrt-2015-000317","article-title":"Systematic oral hydration\u00a0with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data","volume":"2","author":"Agarwal","year":"2015","journal-title":"Open Heart"},{"issue":"7","key":"10.1016\/j.xkme.2020.01.001_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1148\/radiol.13122462","article-title":"Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods","volume":"269","author":"Davenport","year":"2013","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.001_bib43","first-page":"65","article-title":"Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?","volume":"4","author":"Choyke","year":"1998","journal-title":"Tech Urol"},{"issue":"7","key":"10.1016\/j.xkme.2020.01.001_bib44","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ejrad.2015.04.001","article-title":"Screening for impaired renal function in outpatients before iodinated contrast injection: Comparing the Choyke questionnaire with a rapid point-of-care-test","volume":"84","author":"Too","year":"2015","journal-title":"Eur J Radiol"},{"issue":"23","key":"10.1016\/j.xkme.2020.01.001_bib45","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.295.23.2765","article-title":"Prophylaxis strategies for contrast-induced nephropathy","volume":"295","author":"Pannu","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.001_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1253\/circj.70.553","article-title":"Prophylactic hemodialysis does not prevent contrast-induced nephropathy after cardiac catheterization in patients with chronic renal insufficiency","volume":"70","author":"Kawashima","year":"2006","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2011.06.029","article-title":"Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review","volume":"125","author":"Cruz","year":"2012","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1148\/radiol.2015142676","article-title":"Is the presence of a solitary kidney an independent risk factor for acute kidney injury after contrast-enhanced CT?","volume":"278","author":"McDonald","year":"2016","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.001_bib49","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ndt\/gfw338","article-title":"Nephrotoxicity of anticancer treatment","volume":"32","author":"Malyszko","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.001_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfp582","article-title":"Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial","volume":"25","author":"Kiski","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/08860220701742153","article-title":"Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study","volume":"30","author":"Onuigbo","year":"2008","journal-title":"Ren Fail"},{"key":"10.1016\/j.xkme.2020.01.001_bib52","first-page":"32","article-title":"Prevention of radiocontrast-media-induced nephrotoxicity by perindopril and amlodipine in humans","volume":"13","author":"Duan","year":"2003","journal-title":"China J Mod Med"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.001_bib53","first-page":"521","article-title":"Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study","volume":"51","author":"Gupta","year":"1999","journal-title":"Indian Heart J"},{"issue":"5","key":"10.1016\/j.xkme.2020.01.001_bib54","first-page":"305","article-title":"Captopril for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a double-blind placebo controlled clinical trial","volume":"10","author":"Hashemi","year":"2005","journal-title":"J\u00a0Res Med Sci"},{"issue":"2","key":"10.1016\/j.xkme.2020.01.001_bib55","first-page":"280","article-title":"A\u00a0randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention","volume":"23","author":"Shemirani","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"10.1016\/j.xkme.2020.01.001_bib56","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1053\/j.ajkd.2012.04.017","article-title":"The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study","volume":"60","author":"Rim","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2020.01.001_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000366473","article-title":"The impact of renin-angiotensin-aldosterone system blockade on contrast-induced nephropathy: a meta-analysis of 12 studies with 4,493 patients","volume":"130","author":"Jo","year":"2015","journal-title":"Cardiology"},{"issue":"11","key":"10.1016\/j.xkme.2020.01.001_bib59","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of\u00a0GFR\u00a0in children and adolescents","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2020.01.001_bib60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2020.01.001_bib61","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00467-010-1598-7","article-title":"Validation of the revised Schwartz estimating equation in a predominantly non-CKD population","volume":"25","author":"Staples","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2020.01.001_bib62","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.ajkd.2018.05.014","article-title":"Postcontrast acute kidney injury in pediatric patients: a cohort study","volume":"72","author":"McDonald","year":"2018","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520300029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520300029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:19:46Z","timestamp":1762910386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059520300029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2590059520300029"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2020.01.001","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc. on behalf of National Kidney Foundation, Inc. and Radiological Society of North America.","name":"copyright","label":"Copyright"}]}}